MedTrace Logo

Adjustable Fortification of Human Milk Fed to Chinese Preterm Infants

NCT01731613 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2017-11-28

No results posted yet for this study

Summary

This clinical trial will compare how the individualized and fortified human milk feeding will help a premature infant grow.

Conditions

  • Infant, Premature, Diseases

Interventions

DIETARY_SUPPLEMENT

human milk fortifier

Then fortification with human milk fortifier will be initiated at different levels according to the body weight of infants, the protein concentration of human milk and blood urea nitrogen

Sponsors & Collaborators

  • Mead Johnson Nutrition

    collaborator INDUSTRY

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Danhua Wang, Professor · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Days
Max Age
40 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01731613 on ClinicalTrials.gov